Douglas K. Marks

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec”.

Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec

Melanoma Research(2020)10.1097/cmr.0000000000000661

N/A

0DataRank · unranked

17 citations

Megan H. Trager, Robyn D. Gartrell, Emanuelle M. Rizk, Jaya Sarin Pradhan, Andrew M. Silverman +6 more

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Cancer Research(2020)10.1158/0008-5472.can-19-2039

N/A

0DataRank · unranked

31 citations

Andrew Chen, Emanuelle M. Rizk, Douglas K. Marks, Margaret H. Bogardus, Thomas D. Hart +12 more

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.00968

N/A

0DataRank · unranked

27 citations

Robyn D. Gartrell, Margueritta El Asmar, Shuobo Boboila, Thomas D. Hart, Yan Lu +13 more

The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy

Frontiers in Immunology(2021)10.3389/fimmu.2021.654877

N/A

0DataRank · unranked

30 citations

Gina Kim, Panagiota S. Filippou, Luis Rivera Sanchez, David Entenberg, Douglas K. Marks +3 more

Quantitative Multiplex Immunofluorescence Evaluation of the Tumor Microenvironment in Pretreatment Tumors of Patients with Metastatic Breast Cancer and Serous Ovarian Carcinoma Treated with Liposomal Eribulin

Cancer Investigation(2021)10.1080/07357907.2021.1938109

N/A

0DataRank · unranked

0 citations

John Kucharczyk, Pan Kim, Donian Chyong, Robyn D. Gartrell, Yan Lu +9 more

Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer

Clinical Breast Cancer(2022)10.1016/j.clbc.2022.04.002

N/A

0DataRank · unranked

18 citations

Kathleen Fenn, Matthew Kearney, Qi Wang, Hua Guo, Douglas K. Marks +11 more

Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer

The Journal of Pathology(2023)10.1002/path.6155

N/A

0DataRank · unranked

53 citations

Glenn Broeckx, David B. Page, Chowdhury Arif Jahangir, Sara Verbandt, Zuzana Kos +95 more

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer

The Journal of Pathology(2023)10.1002/path.6165

N/A

0DataRank · unranked

51 citations

Glenn Broeckx, Chowdhury Arif Jahangir, Sara Verbandt, Rajarsi Gupta, Jeppe Thagaard +95 more

Data from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma

(2023)10.1158/1078-0432.c.6528354

N/A

0DataRank · unranked

0 citations

Douglas K. Marks, Emanuelle M. Rizk, Margaret H. Bogardus, Camille L. Gérard, Luke W. Barker +15 more

Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer

The Journal of Pathology(2024)10.1002/path.6238

N/A

0DataRank · unranked

16 citations

David B. Page, Glenn Broeckx, Claudia Aura Gonzalez, Caoimbhe Burke, Clodagh Murphy +95 more